Deutsch Barry M. 4
4 · XERIS PHARMACEUTICALS INC · Filed Feb 1, 2021
Insider Transaction Report
Form 4
Deutsch Barry M.
Chief Financial Officer
Transactions
- Award
Common Stock
2021-01-29+115,000→ 208,090 total
Footnotes (1)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These restricted stock units vest in three substantially equal annual installments beginning on January 29, 2022.